Skip to content

Metal Complexes in Medicine: Platinum Drugs, Imaging Agents and Chelation Therapy

CSIR NET chemistry: cisplatin mechanism, carboplatin and oxaliplatin, Gd MRI agents, technetium-99m, chelation therapy, gold, lithium and bismuth drugs.

  • 15 min read
  • Updated
On this page · 15 sections
  1. Prerequisites
  2. The Hook: A Bacterium That Stopped Dividing
  3. Essential, Toxic and Therapeutic
  4. Platinum Anticancer Drugs
  5. Imaging Agents
  6. Chelation Therapy
  7. Other Metallodrugs
  8. Toxic Metals in Brief
  9. Memory Tricks
  10. Don’t Confuse
  11. Common Mistakes
  12. Practice
  13. Quick Revision Table
  14. Key Takeaways
  15. What’s Next

Prerequisites

The Hook: A Bacterium That Stopped Dividing

Essential, Toxic and Therapeutic

Every element shows a dose–response: deficiency at low intake, an optimal range, and toxicity at high intake (a Bertrand diagram). Essential metals (Fe, Zn, Cu, Mn, Co, Mo) and non-essential ones (Pt, Au, Gd, Tc, Li, Bi) are both used in medicine.

UseExamples
Anticancercisplatin, carboplatin, oxaliplatin (Pt); arsenic trioxide (As)
ImagingGd(III) chelates (MRI), ⁹⁹ᵐTc complexes (SPECT), BaSO₄ (X-ray)
Antidotes / chelationBAL, DMSA, CaNa₂EDTA, D-penicillamine, desferrioxamine, Prussian blue
Other drugslithium carbonate, auranofin (Au), bismuth salts, sodium nitroprusside (Fe), silver sulfadiazine, antimony(V) drugs
Supplementsiron salts, zinc, vitamin B₁₂ (Co)

Platinum Anticancer Drugs

Cisplatin: structure and synthesis

cis-Diamminedichloridoplatinum(II), cis-[PtCl₂(NH₃)₂]: square planar Pt(II), \( d^8 \), diamagnetic, neutral.

It is made from K₂[PtCl₄] using the trans effect (Cl⁻ > NH₃): the first NH₃ replaces any Cl⁻; the second replaces a Cl⁻ trans to Cl⁻, giving the cis isomer. (A cleaner route goes through [PtI₄]²⁻, because I⁻ has a still larger trans effect, then exchanges iodide for chloride.) Transplatin is made from [Pt(NH₃)₄]²⁺ and Cl⁻.

Mechanism of action

graph TD
    A[Blood: high chloride, cisplatin stays as PtCl2 NH3 2] --> B[Enters cell: passive diffusion and transporters such as CTR1]
    B --> C[Cell: low chloride, aquation to PtCl NH3 2 H2O +]
    C --> D[Binds N7 of guanine in DNA]
    D --> E[Second aquation and closure: 1,2-intrastrand GpG crosslink]
    E --> F[DNA bent and unwound; HMG proteins bind; replication and transcription blocked]
    F --> G[Apoptosis]
  1. Chloride gradient. Plasma chloride is high (about 100 mM), so cisplatin stays largely intact in the blood. Inside cells chloride is much lower (a few to a few tens of mM), and the complex aquates: Cl⁻ is replaced by water, giving cis-[PtCl(NH₃)₂(H₂O)]⁺, the reactive species. Aquation is the rate-determining activation step.
  2. DNA binding. Pt binds the N7 of guanine (exposed in the major groove, the most nucleophilic site). The main adduct is the 1,2-intrastrand d(GpG) crosslink (the majority of adducts), followed by 1,2-d(ApG); 1,3-intrastrand and interstrand crosslinks are minor.
  3. Structural damage. The crosslink bends the DNA towards the major groove and unwinds it. HMG-domain proteins bind the bent DNA and shield it from repair; replication and transcription stall, and the cell undergoes apoptosis.

Why transplatin is inactive: its two leaving groups are 180° apart, so it cannot form the 1,2-intrastrand crosslink between adjacent guanines. It also reacts faster with other nucleophiles (because the trans ligand labilises), and its adducts are repaired more readily.

Toxicity and resistance. Pt(II) is soft and binds sulfur: glutathione and metallothionein deactivate it, and kidney damage (nephrotoxicity; reduced with hydration) and hearing loss are dose-limiting. Resistance comes from lower uptake, more thiol scavenging and increased nucleotide excision repair.

Second- and third-generation drugs

DrugLeaving groupCarrier (non-leaving) ligandsKey difference
Cisplatin2 Cl⁻2 NH₃most potent, most nephrotoxic
Carboplatincyclobutane-1,1-dicarboxylate (chelating)2 NH₃slower activation, less nephrotoxic; bone-marrow toxicity limits dose; same DNA adducts
Oxaliplatinoxalate (chelating)(1R,2R)-1,2-diaminocyclohexane (DACH)bulky DACH adducts are not recognised by the same repair proteins; active in some cisplatin-resistant tumours (colorectal)

Structure–activity rules (classic, for Pt(II) ammines): neutral complexes; cis geometry; two leaving groups of moderate lability (too labile → reacts with everything before reaching DNA; too inert → never activates); amine carrier ligands with at least one N–H (for hydrogen bonding to DNA).

Pt(IV) prodrugs (octahedral, \( d^6 \), kinetically inert) such as satraplatin carry two extra axial ligands and are reduced to the active Pt(II) inside cells.

Imaging Agents

Gadolinium MRI contrast agents

MRI images water protons. A contrast agent shortens the relaxation time T₁ of nearby water, making those tissues brighter in T₁-weighted images.

Why Gd³⁺: \( 4f^7 \), S = 7/2, seven unpaired electrons (the maximum for an f-block ion), and an \( ^8S \) ground state with no orbital angular momentum, so its electron spin relaxation is slow. That combination makes it the most efficient relaxer of water protons.

Why chelates: free Gd³⁺ is toxic (similar size to Ca²⁺; it blocks calcium channels and precipitates as phosphate). It is given as a very stable, nine-coordinate complex with one water left on the metal:

AgentLigandType
Gadopentetate, [Gd(DTPA)(H₂O)]²⁻DTPA (octadentate)linear
Gadoterate, [Gd(DOTA)(H₂O)]⁻DOTA (octadentate)macrocyclic

Relaxivity (r₁, in mM⁻¹ s⁻¹) depends on: the number of inner-sphere waters (q), their exchange rate with bulk water (must be fast), and the rotational correlation time (slower tumbling, for example when bound to a protein, raises relaxivity). These are combined in the Solomon–Bloembergen–Morgan theory. The observed rate is:

$$\boxed{\frac{1}{T_{1,\text{obs}}} = \frac{1}{T_{1,0}} + r_1[\text{Gd}]}$$

Macrocyclic agents are kinetically more inert than linear ones (Gd³⁺ release is slower). Release of Gd³⁺ from less stable agents in patients with poor kidney function has been linked to nephrogenic systemic fibrosis, which is why kinetic inertness, not just thermodynamic stability, matters here.

Technetium-99m

⁹⁹ᵐTc is the workhorse of nuclear medicine (SPECT): an almost pure γ emitter (isomeric transition) of about 140 keV with a 6-hour half-life, ideal for imaging with little radiation dose.

  • Generator: ⁹⁹Mo (half-life about 66 h), adsorbed on alumina as molybdate, decays to ⁹⁹ᵐTc; saline elutes pertechnetate, TcO₄⁻ (Tc(VII)), while molybdate stays on the column.
  • Kits: a vial contains a ligand and a reductant (usually Sn(II)). Adding TcO₄⁻ reduces Tc to a lower oxidation state, which the ligand captures.
  • Examples: [Tc(MIBI)₆]⁺ (sestamibi, Tc(I), a lipophilic cation for heart imaging, six isonitrile ligands, low-spin \( d^6 \)); Tc–diphosphonate complexes for bone scans; neutral lipophilic Tc(V) complexes for brain perfusion.

Other radiometals: ²⁰¹Tl⁺ (heart, K⁺ mimic), ⁶⁷Ga/⁶⁸Ga and ¹¹¹In (bound to chelators such as DOTA on targeting peptides), ¹⁷⁷Lu (therapy), ²²³Ra (bone metastases, Ca²⁺ mimic).

Chelation Therapy

A good chelating antidote must: bind the target metal selectively (HSAB match) and strongly at physiological pH; not strip essential metals (Ca²⁺, Zn²⁺); reach the metal (lipophilicity, oral or injectable); and give a complex that is excreted (usually via the kidneys).

Poisoning / disorderAgentDonor atomsLogic
As, Hg, (Pb)BAL (British anti-Lewisite, 2,3-dimercaptopropan-1-ol)S, S (O)soft thiols for soft metals; developed against the arsenical war gas lewisite
Pb, Hg, AsDMSA (succimer), DMPSS, Swater-soluble, orally active dithiol analogues of BAL
PbCaNa₂EDTAN₂O₄Pb²⁺ displaces Ca²⁺ (much larger log K); the calcium salt is used so blood Ca²⁺ is not stripped
Cu (Wilson’s disease)D-penicillamine, trientine; also zinc salts (block absorption) and tetrathiomolybdateS, N, Oremoves accumulated copper
Fe overload (thalassaemia, repeated transfusions)desferrioxamine (injectable), deferiprone, deferasirox (oral)mainly O (hydroxamate, hydroxypyridinone, phenolate; deferasirox also uses one triazole N)hard O donors for hard Fe(III)
Tl⁺, ¹³⁷Cs⁺Prussian blue (oral)—ion exchange in the gut; not a chelator

Desferrioxamine B is a bacterial siderophore: a linear molecule with three hydroxamate groups that wraps Fe(III) in a hexadentate, octahedral O₆ environment with an extremely high stability constant (around 10³⁰). Deferiprone is bidentate (3 : 1 complex), deferasirox tridentate (2 : 1).

Other Metallodrugs

DrugMetalUse and chemistry
Lithium carbonateLi⁺bipolar disorder; Li⁺ mimics Mg²⁺ (diagonal relationship) and inhibits Mg-dependent enzymes such as inositol monophosphatase and GSK-3; narrow therapeutic window, blood levels are monitored
AuranofinAu(I)rheumatoid arthritis, oral; linear Au(I) with a thioglucose and triethylphosphine; Au(I) is soft and targets thiol/selenol enzymes (thioredoxin reductase)
Sodium aurothiomalateAu(I)injectable antiarthritic
Bismuth subsalicylate, colloidal bismuth subcitrateBi(III)peptic ulcers, Helicobacter pylori, diarrhoea
Sodium nitroprusside, Na₂[Fe(CN)₅(NO)]Fe(II), NO⁺releases NO, a vasodilator, for hypertensive emergencies; also releases cyanide
Silver sulfadiazineAg(I)antibacterial for burns
Sodium stibogluconateSb(V)leishmaniasis
Arsenic trioxideAs(III)acute promyelocytic leukaemia
Ru(III) complexes (NAMI-A, KP1019)Ruanticancer candidates tested in clinical trials; activated by reduction to Ru(II) in hypoxic tumours
Vanadium complexes (e.g. bis(maltolato)oxovanadium(IV))V(IV)insulin-mimetic research compounds; vanadate mimics phosphate

Toxic Metals in Brief

MetalTarget / mechanismNotes
Pb²⁺binds thiols; inhibits ALA dehydratase (a Zn enzyme) and ferrochelataseanaemia; raised ALA and zinc protoporphyrin
Hg (especially CH₃Hg⁺)very soft, binds thiols; methylmercury crosses membranes and the blood–brain barrierMinamata disease
Cd²⁺replaces Zn²⁺ in enzymes; induces metallothionein; kidney and bone damageitai-itai disease
AsAs(III) binds dithiols (e.g. lipoic acid); arsenate mimics phosphate (uncouples ATP synthesis)BAL, DMSA, DMPS

Memory Tricks

Don’t Confuse

ThisvsThat
Cisplatin: cis, active, 1,2-intrastrand GpGtransplatin: trans, inactive, cannot make 1,2-crosslink
Carboplatin: dicarboxylate leaving group, NH₃ carriersoxaliplatin: oxalate leaving group, DACH carrier
Leaving group (Cl⁻, oxalate): lost on activationcarrier ligand (NH₃, DACH): stays on Pt in the DNA adduct
Gd chelate: T₁ (positive) agentiron oxide nanoparticles: T₂ (negative) agents
Thermodynamic stability of Gd agent (log K)kinetic inertness (rate of Gd³⁺ release)
BAL / DMSA: S donors for soft metalsdesferrioxamine: O donors for Fe(III)
⁹⁹ᵐTc: diagnostic γ emitter¹⁷⁷Lu, ²²³Ra: therapeutic (particle emitters)

Common Mistakes

Practice

All questions below are original practice questions written for this page. They are not from any CSIR NET paper.

Level 1: Foundation

  1. Which atom of guanine does platinum bind in cisplatin–DNA adducts?
  2. What is the oxidation state of technetium in pertechnetate?
  3. Which chelator is used to treat iron overload by injection?
Answers
  1. N7.
  2. +7 (TcO₄⁻).
  3. Desferrioxamine.

Level 2: Part B Style

Practice Q1. Transplatin is inactive as an anticancer drug mainly because:

(a) it cannot enter cells (b) it cannot form 1,2-intrastrand crosslinks between adjacent guanines (c) it does not aquate (d) it is paramagnetic

Answer: (b)

The two labile positions are 180° apart. It aquates and enters cells, and like cisplatin it is \( d^8 \) square planar and diamagnetic.

Practice Q2. Gd³⁺ is preferred over other lanthanide ions for MRI contrast agents because it has:

(a) the largest orbital angular momentum (b) seven unpaired electrons and slow electron spin relaxation (c) the smallest ionic radius (d) intense f–f absorption

Answer: (b)

\( f^7 \), S = 7/2, L = 0 (\( ^8S \)): maximum spin and slow electronic relaxation, the two properties that make proton relaxation efficient.

Practice Q3. The most suitable antidote for acute arsenic poisoning is:

(a) desferrioxamine (b) BAL (dimercaprol) (c) Prussian blue (d) lithium carbonate

Answer: (b)

As(III) is soft and binds dithiols; BAL’s two thiols form a stable five-membered chelate ring. Desferrioxamine is for Fe(III), Prussian blue for Tl⁺/Cs⁺.

Practice Q4. A dose of ⁹⁹ᵐTc (half-life 6.0 h) has an activity of 800 MBq at 8 a.m. Its activity at 2 p.m. and at 8 a.m. the next day are:

(a) 400 and 50 MBq (b) 600 and 100 MBq (c) 400 and 100 MBq (d) 200 and 25 MBq

Answer: (a)

6 h = one half-life: 400 MBq. 24 h = four half-lives: 800/2⁴ = 50 MBq.

Level 3: Part C Style

Practice Q5. In a ⁹⁹Mo/⁹⁹ᵐTc generator, the parent has a half-life of 66 h and the daughter 6.01 h. After an elution removes all ⁹⁹ᵐTc, when does the daughter activity reach its maximum? Use \( t_{max} = \dfrac{\ln(\lambda_d/\lambda_p)}{\lambda_d - \lambda_p} \).

Answer

\( \lambda_p = 0.693/66 = 0.01050 \) h⁻¹; \( \lambda_d = 0.693/6.01 = 0.1153 \) h⁻¹.

\( \ln(\lambda_d/\lambda_p) = \ln(10.98) = 2.396 \); \( \lambda_d - \lambda_p = 0.1048 \) h⁻¹.

\( t_{max} \approx 2.396/0.1048 \approx \) 22.9 h. This is why generators are conveniently eluted about once a day.

Practice Q6. Tissue water has \( T_{1,0} \) = 2.0 s. A Gd agent with relaxivity r₁ = 4.0 mM⁻¹ s⁻¹ (practice value) reaches 0.50 mM in the tissue. Calculate the new T₁. If binding to a protein raised r₁ to 20 mM⁻¹ s⁻¹, what concentration would give the same T₁?

Answer

\( 1/T_1 = 1/2.0 + (4.0)(0.50) = 0.50 + 2.0 = 2.5 \) s⁻¹, so T₁ = 0.40 s.

Same paramagnetic contribution (2.0 s⁻¹) with r₁ = 20: [Gd] = 2.0/20 = 0.10 mM, a fivefold lower dose. Slower tumbling of the protein-bound agent lengthens the rotational correlation time and raises relaxivity.

Practice Q7. Log K values with EDTA (practice values close to literature): Pb²⁺ 18.0, Ca²⁺ 10.7, Zn²⁺ 16.5. Calculate the equilibrium constant for [Ca(EDTA)]²⁻ + Pb²⁺ ⇌ [Pb(EDTA)]²⁻ + Ca²⁺, and comment on whether CaNa₂EDTA might also remove zinc.

Answer

K = K(Pb)/K(Ca) = 10^(18.0 − 10.7) = 10^7.3 ≈ 2.0 × 10⁷: lead displaces calcium essentially completely.

For zinc, K = 10^(16.5 − 10.7) = 10^5.8 ≈ 6 × 10⁵, also highly favourable. So CaNa₂EDTA also mobilises Zn²⁺, and zinc loss is a known side effect of prolonged treatment. EDTA’s selectivity among these metals comes from its total stability constants, not from HSAB softness: it is a hard N₂O₄ donor, which is one reason thiol chelators (DMSA) are preferred for oral lead treatment.

Practice Q8. Consider the statements:

  1. Carboplatin and cisplatin form the same principal DNA adduct because they share the same carrier ligands.
  2. The sestamibi complex contains Tc(I) with six isonitrile ligands and is a cation.
  3. Desferrioxamine binds Fe(III) through six sulfur donors.
  4. Lead poisoning raises δ-aminolevulinic acid levels because lead inhibits ALA dehydratase.

Which are correct?

(a) 1, 2 and 4 only (b) 2 and 3 only (c) 1 and 4 only (d) 1, 2, 3 and 4

Answer: (a)
  1. Correct. After the leaving group is lost, both give cis-{Pt(NH₃)₂}²⁺ bound to the same GpG site. 2. Correct: [Tc(CNR)₆]⁺, Tc(I), low-spin \( d^6 \). 3. Wrong: six hydroxamate O donors (hard donors for hard Fe(III)). 4. Correct.

Practice Q9. A sample contains 180 mg of cisplatin (M = 300.05 g mol⁻¹). How many millimoles of Pt, and what mass of platinum, does it contain? (Pt = 195.08)

Answer

n = 180/300.05 = 0.600 mmol. Mass of Pt = 0.600 × 195.08 ≈ 117 mg (platinum is 65.0% of cisplatin by mass).

Quick Revision Table

IdeaFact
Cisplatincis-[PtCl₂(NH₃)₂], from [PtCl₄]²⁻ (trans effect); aquation inside cells; N7-G; 1,2-d(GpG) crosslink; HMG proteins
Transplatininactive: no 1,2-intrastrand crosslink
Carboplatin / oxaliplatinCBDCA leaving group, slower / oxalate + DACH, active in some resistant tumours
SARneutral, cis, moderately labile leaving groups, N–H carriers
Gd MRI\( f^7 \), S = 7/2; [Gd(DTPA)(H₂O)]²⁻, [Gd(DOTA)(H₂O)]⁻; q = 1; \( 1/T_1 = 1/T_{1,0} + r_1[\text{Gd}] \); macrocycles more inert
⁹⁹ᵐTc140 keV γ, t½ 6 h; ⁹⁹Mo generator (t½ 66 h); TcO₄⁻ + Sn(II) kits; sestamibi Tc(I)
ChelatorsBAL/DMSA/DMPS (As, Hg, Pb); CaNa₂EDTA (Pb); penicillamine (Cu); desferrioxamine, deferiprone, deferasirox (Fe); Prussian blue (Tl, Cs)
Other drugsLi₂CO₃, auranofin (Au(I)), Bi salts, nitroprusside, Ag sulfadiazine, As₂O₃, Sb(V)
Toxic metalsPb (ALA dehydratase, ferrochelatase), Hg (thiols, MeHg), Cd (replaces Zn), As (thiols, phosphate mimic)

Key Takeaways

What’s Next

Advertisement
Advertisement